Alliancebernstein L.P. Magenta Therapeutics, Inc. Transaction History

Alliancebernstein L.P.

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$0.97 - $3.08 $34,726 - $110,264	-35,800 Closed	0 $0
Q3 2021 Nov 10, 2021	SELL	$6.07 - $9.89 $15,175 - $24,725	-2,500 Reduced 6.53%	35,800 $261,000
Q2 2021 Jul 30, 2021	BUY	$9.76 - $14.15 $39,040 - $56,600	4,000 Added 11.66%	38,300 $375,000
Q1 2021 May 06, 2021	SELL	$7.66 - $13.38 $35,236 - $61,548	-4,600 Reduced 11.83%	34,300 $406,000
Q2 2020 Aug 13, 2020	BUY	$6.18 - $10.76 $87,756 - $152,792	14,200 Added 57.49%	38,900 $292,000
Q1 2020 May 14, 2020	BUY	$6.03 - $15.24 $54,873 - $138,684	9,100 Added 58.33%	24,700 $155,000
Q4 2019 Feb 18, 2020	BUY	$9.07 - $15.84 $5,442 - $9,504	600 Added 4.0%	15,600 $236,000
Q3 2019 Nov 14, 2019	BUY	$9.63 - $14.0 $27,927 - $40,600	2,900 Added 23.97%	15,000 $154,000
Q2 2019 Aug 14, 2019	BUY	$13.4 - $17.67 $162,140 - $213,807	12,100 New	12,100 $178,000

442K

Ticker MGTA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 58,890,500
Description
Magenta Therapeutics, Inc., a clinical-stage biotechnology company, develops medicines to bring the curative power of stem cell transplants to patients with blood cancers, genetic diseases, and autoimmune diseases. It develops MGTA-117, an anti-CD117 antibody that targets hematopoietic stem cells (HSCs) and genetically mutated stem cells that ca...

Get notified when there are updates to the investment portfolio of Alliancebernstein L.P., based on Form 13F filings with the SEC.

Stay updated on Alliancebernstein L.P. with notifications on news.